Kriska BioTech ApS: Financial statements 2018
CVR: 37591971
Source: annual report 2018, Danish Business Authority
01/10/2017 – 30/09/2018
Kriska BioTech ApS (CVR 37591971) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 102,513 and a net result of DKK 43,766. Equity in the 2018 report amounted to DKK 80,854. The solvency ratio was 23.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 102,513
- Profit/Loss
- DKK 43,766
- Equity
- DKK 80,854
- Total Assets
- DKK 340,844
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Kriska BioTech ApS has published its interim report for the period April 1, 2016 – September 30, 2017.
About Kriska BioTech ApS
Kriska BioTech ApS is a Danish company of the type Anpartsselskab based in Gedsted, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Karsten Kristoffersen. The company is owned by Hans Karsten Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -25,405 and a net result of DKK -49,612 compared with DKK -44,384 the year before. Equity in the 2025 report amounted to DKK -425,023.